| 2024/05/03 17:30:00 | |
|---|---|
| Price | |
| 0.9065 EUR | |
| Difference | 1.31% (0.01) |
General attributes
| ISIN | NL0010391025 |
| Symbol | PHARM |
| Exchange | London Stock Exchange European Trade Reporting |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 603 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | 0.884 EUR (75,000) |
| Ask (Ask size) | 0.929 EUR (75,000) |
| Open | 0.904 EUR |
| High | 0.9065 EUR |
| Low | 0.904 EUR |
| Close (prev. day) | 0.8948 EUR |
| VWAP | 1.10 EUR |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | 2 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: PHARMING GROUP N.V. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/03 17:30:00 | |
|---|---|
| Price | |
| 0.9065 EUR | |
| Difference | 1.31% (0.01) |
General attributes
| ISIN | NL0010391025 |
| Symbol | PHARM |
| Exchange | London Stock Exchange European Trade Reporting |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 603 EUR |
| Benchmark | AMSTERDAM EXCHANGES INDEX |
Market data
| Bid (Bid size) | 0.884 EUR (75,000) |
| Ask (Ask size) | 0.929 EUR (75,000) |
| Open | 0.904 EUR |
| High | 0.9065 EUR |
| Low | 0.904 EUR |
| Close (prev. day) | 0.8948 EUR |
| VWAP | 1.10 EUR |
| Volume (pcs) | - |
| Trading volume | - |
| Number of trades | 2 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -21.07% | -10.40% | -14.30% |
| Perf (abs.) | -0.24 | -0.11 | -0.15 |
| Beta | 1.04 | 0.75 | 0.76 |
| Volatility | 32.59 | 36.12 | 40.88 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.8922 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.9591 EUR (0) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 1.0448 EUR (22,771) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 1.0890 EUR (21,037) |
| YTD High | date | 1.2000 EUR (2024/01/10) |
| YTD Low | date | 0.8793 EUR (2024/04/19) |
| 52 Weeks High | date | 1.2990 EUR (2023/09/18) |
| 52 Weeks Low | date | 0.8793 EUR (2024/04/19) |
All listings for PHARMING GROUP N.V.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/03 | 22:26 | 0.9025 EUR | 0.01 | 5 |
| Stuttgart | 2024/05/03 | 16:26 | 0.8255 EUR | 0.00 | 12 |
| Munich | 2024/05/03 | 08:03 | 0.8955 EUR | 0.00 | 2 |
| London Stock Exchange European Trade Reporting | 2024/05/03 | 17:30 | 0.9065 EUR | 0.00 | 2 |
| Frankfurt | 2024/05/03 | 08:02 | 0.889 EUR | 0.00 | 2 |
| FINRA other OTC Issues | 2024/04/26 | 18:35 | 0.9539 USD | 0.00 | 1 |
| Euronext Amsterdam | 2024/05/03 | 17:35 | 0.8985 EUR | 4.22 | 1,259 |
| Duesseldorf | 2024/05/03 | 08:10 | 0.89 EUR | 0.00 | 3 |
| Berlin | 2024/05/03 | 08:04 | 0.896 EUR | 0.00 | 2 |
Company Logo
Contact Details
| PHARMING GROUP NV |
| - - |
| Darwinweg 24 - 2333 CR Leiden |
| Telefon: +31-71-524-74-00 |
| Fax: + |
| E-mail: info@pharming.com |
PDF Downloads
| Company report: PHARMING GROUP N.V. | |
Company Profile
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands. |
Members of Management Board
| Sijmen de Vries | Chairman of Managing Board |
| Anurag Relan | Member of Executive Committee |
| Jeroen Wakkerman | Member of Executive Committee |
| Mireille Sanders | Member of Executive Committee |
| Ruud van Outersterp | Member of Executive Committee |
| Stephen Toor | Member of Executive Committee |
Board of directors
| Richard Peters | Chairman of Supervisory Board |
| Jabine T. M. van der Meijs | Member of Supervisory Board |
| Mark Pykett | Member of Supervisory Board |
| Barbara Yanni | Member of Supervisory Board |
| Deborah Jorn | Member of Supervisory Board |
| Leonard Kruimer | Member of Supervisory Board |
| Steven Baert | Member of Supervisory Board |